Articles > Newspapers > International Newspapers, Major Markets > Health & Medicine Week articles > September 2003

Article: ANDA approval granted for Trimethobenzamide 300-mg capsules.

Article from:
Health & Medicine Week
Article date:
September 29, 2003
Copyright

2003 SEP 29 - (NewsRx.com & NewsRx.net) -- United Research Laboratories and Mutual Pharmaceutical Co. announced that Mutual Pharmaceutical has received U.S. Food and Drug Administration (FDA) approval of its abbreviated new drug application (ANDA) for Trimethobenzamide 300-mg capsules.

Mutual will begin shipping its Trimethobenzamide 300-mg capsules immediately.

Mutual's Trimethobenzamide 300-mg capsules are AB-rated to, and therefore the generic equivalent of, King Pharmaceuticals' Tigan Capsules.

United Research ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: United Research Laboratories/Mutual ...
PR Newswire;  August 23, 2006 ;     700+ words ... ... Officer of United Research Laboratories/Mutual Pharmaceutical Company. A copy ... About United Research Laboratories/Mutual Pharmaceutical Company United Research Laboratories/Mutual Pharmaceutical Company is a leading ...

Article: Collegium Pharmaceutical Inc. and United Research ...
Business Wire;  April 20, 2005 ;     700+ words ... ... Officer of United Research Laboratories/Mutual Pharmaceutical Company said ... About United Research Laboratories/Mutual Pharmaceutical Company United Research Laboratories/Mutual Pharmaceutical Company, a privately ...

Article: United Research Laboratories/Mutual ...
PR Newswire;  September 7, 2006 ;     700+ words ... ... Officer of United Research Laboratories/Mutual Pharmaceutical Company. A copy ... About United Research Laboratories/Mutual Pharmaceutical Company United Research Laboratories/Mutual Pharmaceutical Company is a leading ...

Article: United Research Laboratories/Mutual ...
Health & Medicine Week;  March 10, 2003 ;     700+ words ... ... amp; NewsRx.net) -- United Research Laboratories/Mutual Pharmaceutical Co. announced that the company achieved ... development and commercialization. United Research Laboratories/Mutual Pharmaceutical Co., a privately held company headquartered ...

Article: Another generic form of Prozac receives okay from the FDA. ...
Chain Drug Review;  March 18, 2002 ;     618 words ...United Research Laboratories/Mutual Pharmaceutical Co. announced that ... Administration has approved Mutual Pharmaceutical's abbreviated ... under both United Research Laboratories and Mutual Pharmaceutical labels. The approval ...

Article: United Research Laboratories/Mutual ...
Chain Drug Review;  September 29, 2003 ;     700+ words ... ... urlmutual.com Key contacts: William Sirico, director of marketing PHILADELPHIA -- United Research Laboratories/Mutual Pharmaceutical Co. is on track to rack up its fourth straight year of record sales, executives say. "Our continued ...

Article: United Research Laboratories/Mutual ...
Chemical Market Reporter;  March 4, 2002 ;     530 words ...UNITED Research Laboratories/Mutual Pharmaceutical Company has received FDA approval for generic versions of Bristol-Myers Squibb Company's Glucophage (metformin) tablets.

Article: United Research Laboratories/Mutual ...
PR Newswire;  August 18, 2006 ;     700+ words ...PHILADELPHIA, Aug. 18 /PRNewswire/ -- United Research Laboratories and Mutual Pharmaceutical Company today announce that Mutual has filed an Abbreviated New Drug Application (ANDA) with the Food and Drug Administration ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives